Cellyan Biotechnology Co

HKPD - Cellyan Biotechnology Co • Financials

Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
03/2023
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
03/2024
17
3
-
8%
0.18
4
31%
1
0.21
-0
-0
1
-0
0
0
-
-
03/2025
20
1
-
L
L
5
L
-2
-
1
-0
2
0
0
0
-
-
03/2026
13
-0
-
L
L
10
L
-0
-
-1
-0
-1
-1
0
0
-
-